Alpha interferon administration to infants with congenital rubella

Antimicrob Agents Chemother. 1982 Feb;21(2):259-61. doi: 10.1128/AAC.21.2.259.

Abstract

Three infants with congenital rubella syndrome were given human leukocyte (alpha) interferon at doses of 2 x 10(5) to 7 X 10(5) U/kg per day for 10 days. A transient decrease in pharyngeal virus excretion was observed with treatment. No significant side effects were associated with the administration of human leukocyte interferon to these infants.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Humans
  • Immunoenzyme Techniques
  • Infant
  • Interferons / therapeutic use*
  • Pharynx / microbiology
  • Rubella / congenital*
  • Rubella / microbiology
  • Rubella / therapy
  • Rubella virus / isolation & purification

Substances

  • Interferons